Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Serena Williams on Using GLP-1 Medication Before Controversial Super Bowl Ad

Serena Williams highlights her 34-pound weight loss and improved energy using GLP-1 medication in a Super Bowl ad for telehealth company Ro.

  • Yesterday, Serena Williams, the 23-time Grand Slam champion, appeared in a Super Bowl telecast promoting GLP-1 weight-loss treatment during the Seattle Seahawks vs New England Patriots at Levi's Stadium.
  • After consulting medical professionals, Williams began GLP-1 treatment in 2024 post-breastfeeding, citing postpartum weight struggles and partnered with telehealth company Ro using Zepbound.
  • She reported losing 34 pounds over a year using GLP-1 medications and highlighted reduced knee joint stress and stabilized blood sugar levels.
  • Viewers reacted angrily, flooding social media with comments calling the commercial `disgusting` and `shameful` while linking Williams' endorsement to Alexis Ohanian, her husband and Ro investor.
  • With an estimated 130 million viewers, the Super Bowl telecast amplified debate as the World Anti-Doping Agency monitors GLP-1 use and Adrian Bassett confirmed Williams rejoined the drug-testing pool.
Insights by Ground AI

17 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 56% of the sources lean Left
56% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Daily Express broke the news in United Kingdom on Sunday, February 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal